UK +44 (0)1865 849841
Malaysia +60 3 2117 5193

Tag: biotech

Biobanking, Therapeutics & Probiotics in Microbiome Research

As the world becomes increasingly aware of the important role that different bacterial ecosystems play with regards to human and animal health, there is a growing wealth of research coming out of the microbiome industry. Kristina Campbell & Marilyn White, of KC Microbiome, conducted these interviews at the Microbiome R&D and Business Collaboration Forum: USA.

Read More

Use and misuse of CRISPR/Cas9 genome editing

Since its discovery in 2012, the use of the CRISPR/Cas9 system to edit genomes has raised the expectations for the cure of untreatable disorders. Very often, as biomedical geneticists we found ourselves talking about the potentials and drawbacks of CRIPSR/Cas9 both at scientific and layman level.

Read More

A Model Approach To Microbiome Therapeutics

By any measure, momentum in the microbiome space keeps building. The 2017 Silicon Valley Bank mid-year Microbiome Investment Trends report provides one of the most up-to-date snapshots: close to USD 1 billion has been invested in microbiome companies globally since 2010, and SVB’s analysts predict the total capital in disclosed equity investments in 2017 alone could be reaching north of USD 400 million by year-end. And my own analysis of Microbiome Partnership Trends, published earlier this year, documents the dramatic increase in partnerships during 2016, a trend that has shown no signs of slowing down.

Read More

Subscribe to Our Newsletter

Get free reports and resources from our world class speakers.
  • This field is for validation purposes and should be left unchanged.

Life Sciences Twitter Feed

Archive